Scientists Uncover Microglia’s Role as Project Managers of Brain Immunity

New research uncovers the essential role of microglia and MAVS signaling in coordinating immune responses against viral infections in the brain, offering promising insights for future therapies.
Infections in the brain can have severe and often fatal consequences, owing to the unique manner in which the immune system operates within this vital organ. A recent study conducted by researchers at TWINCORE, the Center for Experimental and Clinical Infection Research in Hanover, has shed light on the crucial signaling pathways that facilitate communication among immune cells in the brain during viral infections. Published in the Journal of Neuroinflammation, the research highlights how microglia, the brain’s resident immune cells, act as central coordinators in the brain’s defense against viruses.
The immune response in the brain involves complex interactions where infected cells are identified and eliminated to prevent the spread of viruses like vesicular stomatitis virus (VSV). Microglia, often considered the project managers of brain immunity, recognize these infections and communicate with T cells to mount a coordinated defense.
Dr. Andreas Pavlou from TWINCORE explains that microglia's role is mediated through specific signaling pathways. The team investigated the importance of MAVS—mitochondrial antiviral-signaling protein—in this process. Using mouse models with targeted deletion of MAVS in different cell types, the researchers discovered that removing MAVS from microglia significantly impeded immune coordination, leading to rapid viral spread within the brain. In contrast, deleting MAVS from neurons or astrocytes had little effect.
The findings revealed that microglia with functional MAVS receptors maintain proper signaling surface receptors and metabolic activity in T cells, enabling an effective immune response. When MAVS was absent, microglia failed in their coordinator role, resulting in disrupted communication with T cells and weakened immunity.
Professor Ulrich Kalinke emphasized that understanding MAVS’s role offers potential for developing new therapeutic strategies to combat brain infections more effectively, potentially improving patient outcomes in the future. Overall, this study emphasizes the microglia’s critical function as immune system project managers in the brain, orchestrating protective responses against viral threats.
Source: https://medicalxpress.com/news/2025-07-immune-defense-brain.html
Stay Updated with Mia's Feed
Get the latest health & wellness insights delivered straight to your inbox.
Related Articles
Boehringer Ingelheim Receives U.S. Approval for Innovative Lung Cancer Treatment
Boehringer Ingelheim has received FDA approval for zongertinib, a new oral treatment for HER2-mutant non-small cell lung cancer, offering hope for patients with limited options.
Customized Deep Brain Stimulation Enhances Gait in Parkinson's Disease Patients
Innovative personalized deep brain stimulation techniques are showing promise in improving walking and gait stability in Parkinson's disease patients, leading to better mobility and quality of life.
Real-World Data Demonstrates Benefits of Teclistamab for Diverse Multiple Myeloma Patients
New real-world evidence shows that teclistamab can provide meaningful benefits to a broader range of multiple myeloma patients, including those with high-risk features and previous therapies, beyond the initial clinical trial population.
How a Multiple Sclerosis Medication Alters the Immune System Mechanisms
Recent research uncovers how the MS drug ocrelizumab influences immune cell behavior, revealing complex mechanisms that improve treatment outcomes and advance understanding of autoimmune processes.